The role of an alginate suspension on pepsin and bile acids - key aggressors in the gastric refluxate. Does this have implications for the treatment of gastro-oesophageal reflux disease?
about
Reflux revisited: advancing the role of pepsinOM2, a Novel Oligomannuronate-Chromium(III) Complex, Promotes Mitochondrial Biogenesis and Lipid Metabolism in 3T3-L1 Adipocytes via the AMPK-PGC1α PathwayCurrent pharmacological management of gastroesophageal reflux disease.Alginate drug delivery systems: application in context of pharmaceutical and biomedical research.Effect of alginate in patients with GERD hiatal hernia matters.Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease.Alginate as a protease inhibitor in vitro and in a model gut system; selective inhibition of pepsin but not trypsin.Layer-by-Layer Encapsulation of Probiotics for Delivery to the Microbiome.Bile Salts at Low pH Cause Dilation of Intercellular Spaces in In Vitro Stratified Primary Esophageal Cells, Possibly by Modulating Wnt Signaling.Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlledAssessment and protection of esophageal mucosal integrity in patients with heartburn without esophagitis.Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.
P2860
Q21285006-705EEBC6-244A-427C-A44D-8F22EF25C6F7Q28546556-0E359D24-AF82-4605-9DCE-35B364F7FAA2Q38123482-6857B042-20F0-4C6A-9F15-2E7C3F75731BQ38238527-EB4B3891-05CD-402D-B9C4-C083846C4567Q38599589-4936284A-2C9D-48A2-A53D-474D2B2DC6C7Q42261445-A8BB10BD-9FA0-4EF9-B49E-7D29549E8842Q42562212-2C84B1A2-0697-4B46-A41A-0CE9A3F4DF32Q43097131-E483A0C4-8D45-4EF7-89B0-CAE5FCC634F5Q45024270-CBD4F1BA-22A6-45A1-8C5A-88AB8F2A48C8Q45835157-2F65CC43-4F9B-4C0A-9A5A-5EEEF1DA8CADQ46046339-1B79B9A0-4E70-4EFE-BDD5-52A681098233Q50129556-643E2E85-7860-4DDB-959F-1852EA5F4C20
P2860
The role of an alginate suspension on pepsin and bile acids - key aggressors in the gastric refluxate. Does this have implications for the treatment of gastro-oesophageal reflux disease?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The role of an alginate suspen ...... ro-oesophageal reflux disease?
@en
The role of an alginate suspen ...... ro-oesophageal reflux disease?
@nl
type
label
The role of an alginate suspen ...... ro-oesophageal reflux disease?
@en
The role of an alginate suspen ...... ro-oesophageal reflux disease?
@nl
prefLabel
The role of an alginate suspen ...... ro-oesophageal reflux disease?
@en
The role of an alginate suspen ...... ro-oesophageal reflux disease?
@nl
P2093
P2860
P356
P1476
The role of an alginate suspen ...... ro-oesophageal reflux disease?
@en
P2093
Ian G Jolliffe
Jeanine Avis
Lesley M Johnstone
Peter W Dettmar
Vicki Strugala
P2860
P304
P356
10.1211/JPP.61.08.0005
P577
2009-08-01T00:00:00Z